Gal‐9 mRNA in MDSCs from MDS patients (n = 12, samples: 001, 004‐007, 016, 018, 024, and 031‐034) was higher than that in NC (3.49 (2.09‐12.57) vs 0.99 (0.50‐2.50), P < .05*) (Figure 1D). The gene discussed is LGALS9; the disease is myelodysplastic syndrome.